• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

NOD 样受体蛋白 3 的激活会导致自发性炎症和纤维化,类似于人类的 NASH。

NOD-like receptor protein 3 activation causes spontaneous inflammation and fibrosis that mimics human NASH.

机构信息

Department of Bioengineering, University of California San Diego, San Diego, California, USA.

Department of Pediatrics, University of California San Diego, San Diego, California, USA.

出版信息

Hepatology. 2022 Sep;76(3):727-741. doi: 10.1002/hep.32320. Epub 2022 Mar 1.

DOI:10.1002/hep.32320
PMID:34997987
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10176600/
Abstract

BACKGROUND AND AIMS

The NOD-like receptor protein 3 (NLRP3) inflammasome is a central contributor to human acute and chronic liver disease, yet the molecular and cellular mechanisms by which its activation precipitates injury remain incompletely understood. Here, we present single cell transcriptomic profiling of livers from a global transgenic tamoxifen-inducible constitutively activated Nlrp3 mutant mouse, and we investigate the changes in parenchymal and nonparenchymal liver cell gene expression that accompany inflammation and fibrosis.

APPROACH AND RESULTS

Our results demonstrate that NLRP3 activation causes chronic extramedullary myelopoiesis marked by myeloid progenitors that differentiate into proinflammatory neutrophils, monocytes, and monocyte-derived macrophages. We observed prominent neutrophil infiltrates with increased Ly6g and Ly6g cells exhibiting transcriptomic signatures of granulopoiesis typically found in the bone marrow. This was accompanied by a marked increase in Ly6c monocytes differentiating into monocyte-derived macrophages that express transcriptional programs similar to macrophages of NASH models. NLRP3 activation also down-regulated metabolic pathways in hepatocytes and shifted hepatic stellate cells toward an activated profibrotic state based on expression of collagen and extracellular matrix regulatory genes.

CONCLUSIONS

These results define the single cell transcriptomes underlying hepatic inflammation and fibrosis precipitated by NLRP3 activation. Clinically, our data support the notion that NLRP3-induced mechanisms should be explored as therapeutic target in NASH-like inflammation.

摘要

背景和目的

NOD 样受体蛋白 3(NLRP3)炎症小体是导致人类急性和慢性肝病的重要因素,但目前仍不完全清楚其激活引发损伤的分子和细胞机制。在此,我们对来自全球转基因他莫昔芬诱导型组成性激活 NLRP3 突变小鼠的肝脏进行了单细胞转录组谱分析,并研究了伴随炎症和纤维化的实质细胞和非实质细胞基因表达的变化。

方法和结果

我们的研究结果表明,NLRP3 激活导致慢性骨髓外髓样细胞生成,表现为髓样前体细胞分化为促炎中性粒细胞、单核细胞和单核细胞衍生的巨噬细胞。我们观察到明显的中性粒细胞浸润,Ly6g 和 Ly6g 细胞增加,这些细胞表现出通常在骨髓中发现的粒细胞生成的转录组特征。这伴随着 Ly6c 单核细胞的显著增加,这些单核细胞分化为表达类似于 NASH 模型中巨噬细胞的转录程序的单核细胞衍生的巨噬细胞。NLRP3 激活还下调了肝细胞中的代谢途径,并根据胶原和细胞外基质调节基因的表达将肝星状细胞推向激活的促纤维化状态。

结论

这些结果定义了 NLRP3 激活引发的肝炎症和纤维化的单细胞转录组。临床上,我们的数据支持 NLRP3 诱导的机制应作为 NASH 样炎症的治疗靶点进行探索的观点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b719/10176600/598ae8baca8e/nihms-1770223-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b719/10176600/3e7c475ba50e/nihms-1770223-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b719/10176600/d6e3714f75f1/nihms-1770223-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b719/10176600/f5943a0b15bf/nihms-1770223-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b719/10176600/0245834113e9/nihms-1770223-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b719/10176600/e898b33c89dd/nihms-1770223-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b719/10176600/598ae8baca8e/nihms-1770223-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b719/10176600/3e7c475ba50e/nihms-1770223-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b719/10176600/d6e3714f75f1/nihms-1770223-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b719/10176600/f5943a0b15bf/nihms-1770223-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b719/10176600/0245834113e9/nihms-1770223-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b719/10176600/e898b33c89dd/nihms-1770223-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b719/10176600/598ae8baca8e/nihms-1770223-f0006.jpg

相似文献

1
NOD-like receptor protein 3 activation causes spontaneous inflammation and fibrosis that mimics human NASH.NOD 样受体蛋白 3 的激活会导致自发性炎症和纤维化,类似于人类的 NASH。
Hepatology. 2022 Sep;76(3):727-741. doi: 10.1002/hep.32320. Epub 2022 Mar 1.
2
BRP39 Regulates Neutrophil Recruitment in NLRP3 Inflammasome-Induced Liver Inflammation.BRP39 调控 NLRP3 炎性小体诱导的肝炎症中的中性粒细胞募集。
Cell Mol Gastroenterol Hepatol. 2024;17(3):481-497. doi: 10.1016/j.jcmgh.2023.12.002. Epub 2023 Dec 12.
3
NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice.NLRP3炎性小体阻断可减轻小鼠实验性非酒精性脂肪性肝炎中的肝脏炎症和纤维化。
J Hepatol. 2017 May;66(5):1037-1046. doi: 10.1016/j.jhep.2017.01.022. Epub 2017 Feb 3.
4
Hepatocyte pyroptosis and release of inflammasome particles induce stellate cell activation and liver fibrosis.肝细胞焦亡和炎性小体颗粒的释放诱导肝星状细胞活化和肝纤维化。
J Hepatol. 2021 Jan;74(1):156-167. doi: 10.1016/j.jhep.2020.07.041. Epub 2020 Aug 4.
5
Pharmacology of a Potent and Novel Inhibitor of the NOD-Like Receptor Pyrin Domain-Containing Protein 3 (NLRP3) Inflammasome that Attenuates Development of Nonalcoholic Steatohepatitis and Liver Fibrosis.一种新型强效 NOD 样受体热蛋白结构域相关蛋白 3(NLRP3)炎症小体抑制剂的药理学研究,该抑制剂可减轻非酒精性脂肪性肝炎和肝纤维化的发展。
J Pharmacol Exp Ther. 2023 Aug;386(2):242-258. doi: 10.1124/jpet.123.001639. Epub 2023 Jun 12.
6
Cell-specific Deletion of NLRP3 Inflammasome Identifies Myeloid Cells as Key Drivers of Liver Inflammation and Fibrosis in Murine Steatohepatitis.细胞特异性 NLRP3 炎性小体缺失鉴定出髓系细胞是小鼠脂肪性肝炎中肝脏炎症和纤维化的关键驱动因素。
Cell Mol Gastroenterol Hepatol. 2022;14(4):751-767. doi: 10.1016/j.jcmgh.2022.06.007. Epub 2022 Jul 2.
7
Neutrophil extracellular traps activate hepatic stellate cells and monocytes via NLRP3 sensing in alcohol-induced acceleration of MASH fibrosis.中性粒细胞胞外诱捕网通过 NLRP3 感应激活肝星状细胞和单核细胞,加速酒精诱导的 MASH 纤维化。
Gut. 2024 Oct 7;73(11):1854-1869. doi: 10.1136/gutjnl-2023-331447.
8
ASK1 inhibition reduces cell death and hepatic fibrosis in an Nlrp3 mutant liver injury model.ASK1 抑制可减少 NLRP3 突变型肝损伤模型中的细胞死亡和肝纤维化。
JCI Insight. 2020 Jan 30;5(2):123294. doi: 10.1172/jci.insight.123294.
9
NLRP3 inflammasome activation is required for fibrosis development in NAFLD.NLRP3炎性小体激活是NAFLD中纤维化发展所必需的。
J Mol Med (Berl). 2014 Oct;92(10):1069-82. doi: 10.1007/s00109-014-1170-1. Epub 2014 May 28.
10
NLRP3 inflammasome in hepatic diseases: A pharmacological target.NLRP3 炎性小体在肝脏疾病中的作用:一个药理学靶点。
Biochem Pharmacol. 2023 Nov;217:115861. doi: 10.1016/j.bcp.2023.115861. Epub 2023 Oct 18.

引用本文的文献

1
Combination Therapy of Half-Dose Resmetirom and Metformin Attenuates Metabolic Dysfunction-Associated Steatohepatitis Through Improving Cholesterol Metabolism and Inflammation.半剂量瑞美鲁肽与二甲双胍联合治疗通过改善胆固醇代谢和炎症减轻代谢功能障碍相关脂肪性肝炎
Biomedicines. 2025 May 27;13(6):1315. doi: 10.3390/biomedicines13061315.
2
A Comparative Study of N-Acetyl Cysteine, Rosuvastatin, and Vitamin E in the Management of Patients with Non-Alcoholic Steatohepatitis: A Randomized Controlled Trial.N-乙酰半胱氨酸、瑞舒伐他汀和维生素E治疗非酒精性脂肪性肝炎患者的比较研究:一项随机对照试验
Pharmaceuticals (Basel). 2025 Apr 29;18(5):650. doi: 10.3390/ph18050650.
3

本文引用的文献

1
Therapeutic pipeline in nonalcoholic steatohepatitis.非酒精性脂肪性肝炎的治疗药物研发管线。
Nat Rev Gastroenterol Hepatol. 2021 Jun;18(6):373-392. doi: 10.1038/s41575-020-00408-y. Epub 2021 Feb 10.
2
Dynamic Shifts in the Composition of Resident and Recruited Macrophages Influence Tissue Remodeling in NASH.动态变化的驻留巨噬细胞和募集巨噬细胞组成影响 NASH 组织重塑。
Cell Rep. 2021 Jan 12;34(2):108626. doi: 10.1016/j.celrep.2020.108626.
3
Functional adaptive landscapes predict terrestrial capacity at the origin of limbs.功能适应景观预测了肢体起源处的陆地能力。
Dehydrotrametenolic acid methyl ester, a triterpenoid of Poria cocos, alleviates non-alcoholic steatohepatitis by suppressing NLRP3 inflammasome activation via targeting Caspase-1 in mice.
茯苓三萜酸甲酯是茯苓中的一种三萜类化合物,通过靶向小鼠中的半胱天冬酶-1抑制NLRP3炎性小体激活,从而减轻非酒精性脂肪性肝炎。
Acta Pharmacol Sin. 2025 May 6. doi: 10.1038/s41401-025-01569-9.
4
Spatially clustered type I interferon responses at injury borderzones.在损伤边界区存在空间聚集的 I 型干扰素反应。
Nature. 2024 Sep;633(8028):174-181. doi: 10.1038/s41586-024-07806-1. Epub 2024 Aug 28.
5
Rab11b promotes M1-like macrophage polarization by restraining autophagic degradation of NLRP3 in alcohol-associated liver disease.在酒精性肝病中,Rab11b通过抑制NLRP3的自噬降解来促进M1样巨噬细胞极化。
Acta Pharmacol Sin. 2025 Jan;46(1):134-146. doi: 10.1038/s41401-024-01333-5. Epub 2024 Jul 11.
6
Neutrophil extracellular traps activate hepatic stellate cells and monocytes via NLRP3 sensing in alcohol-induced acceleration of MASH fibrosis.中性粒细胞胞外诱捕网通过 NLRP3 感应激活肝星状细胞和单核细胞,加速酒精诱导的 MASH 纤维化。
Gut. 2024 Oct 7;73(11):1854-1869. doi: 10.1136/gutjnl-2023-331447.
7
Vitamin D Mitigates Hepatic Fat Accumulation and Inflammation and Increases SIRT1/AMPK Expression in AML-12 Hepatocytes.维生素 D 可减轻 AML-12 肝细胞中的肝脂肪堆积和炎症,并增加 SIRT1/AMPK 的表达。
Molecules. 2024 Mar 21;29(6):1401. doi: 10.3390/molecules29061401.
8
Hepatic danger signaling triggers TREM2 macrophage induction and drives steatohepatitis via MS4A7-dependent inflammasome activation.肝危险信号触发 TREM2 巨噬细胞诱导,并通过 MS4A7 依赖性炎性小体激活导致脂肪性肝炎。
Sci Transl Med. 2024 Mar 13;16(738):eadk1866. doi: 10.1126/scitranslmed.adk1866.
9
Innate and adaptive immune cell interaction drives inflammasome activation and hepatocyte apoptosis in murine liver injury from immune checkpoint inhibitors.先天和适应性免疫细胞相互作用驱动免疫检查点抑制剂诱导的小鼠肝损伤中的炎症小体激活和肝细胞凋亡。
Cell Death Dis. 2024 Feb 14;15(2):140. doi: 10.1038/s41419-024-06535-7.
10
The discovery of NLRP3 and its function in cryopyrin-associated periodic syndromes and innate immunity.NLRP3 的发现及其在 Cryopyrin 相关周期性综合征和先天免疫中的作用。
Immunol Rev. 2024 Mar;322(1):259-282. doi: 10.1111/imr.13292. Epub 2023 Dec 25.
Nature. 2021 Jan;589(7841):242-245. doi: 10.1038/s41586-020-2974-5. Epub 2020 Nov 25.
4
Osteopontin Expression Identifies a Subset of Recruited Macrophages Distinct from Kupffer Cells in the Fatty Liver.骨桥蛋白表达鉴定了肝脂肪变性中招募的巨噬细胞亚群,与枯否细胞不同。
Immunity. 2020 Sep 15;53(3):641-657.e14. doi: 10.1016/j.immuni.2020.08.004. Epub 2020 Sep 3.
5
The Power of Single-Cell Analysis for the Study of Liver Pathobiology.单细胞分析在肝脏病理生物学研究中的作用。
Hepatology. 2021 Jan;73(1):437-448. doi: 10.1002/hep.31485.
6
Single-cell technologies in hepatology: new insights into liver biology and disease pathogenesis.单细胞技术在肝脏病学中的应用:对肝脏生物学和疾病发病机制的新认识。
Nat Rev Gastroenterol Hepatol. 2020 Aug;17(8):457-472. doi: 10.1038/s41575-020-0304-x. Epub 2020 Jun 1.
7
Niche-Specific Reprogramming of Epigenetic Landscapes Drives Myeloid Cell Diversity in Nonalcoholic Steatohepatitis.特定龛位的表观遗传景观重编程驱动非酒精性脂肪性肝炎中髓系细胞的多样性。
Immunity. 2020 Jun 16;52(6):1057-1074.e7. doi: 10.1016/j.immuni.2020.04.001. Epub 2020 May 1.
8
Pathogenesis of Nonalcoholic Steatohepatitis: An Overview.非酒精性脂肪性肝炎的发病机制:概述
Hepatol Commun. 2020 Jan 14;4(4):478-492. doi: 10.1002/hep4.1479. eCollection 2020 Apr.
9
ASK1 inhibition reduces cell death and hepatic fibrosis in an Nlrp3 mutant liver injury model.ASK1 抑制可减少 NLRP3 突变型肝损伤模型中的细胞死亡和肝纤维化。
JCI Insight. 2020 Jan 30;5(2):123294. doi: 10.1172/jci.insight.123294.
10
Resolving the fibrotic niche of human liver cirrhosis at single-cell level.解析人肝硬化的纤维性龛位于单细胞水平。
Nature. 2019 Nov;575(7783):512-518. doi: 10.1038/s41586-019-1631-3. Epub 2019 Oct 9.